<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01302210</url>
  </required_header>
  <id_info>
    <org_study_id>AHRQ 1R18HSO19968-01</org_study_id>
    <nct_id>NCT01302210</nct_id>
  </id_info>
  <brief_title>Detection, Education, Research and Decolonization Without Isolation in Long-term Care Facilities</brief_title>
  <acronym>DERAIL_MRSA</acronym>
  <official_title>Detection, Education, Research and Decolonization Without Isolation in Long-term Care to Control(DERAIL)MRSA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NorthShore University HealthSystem Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agency for Healthcare Research and Quality (AHRQ)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>NorthShore University HealthSystem Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our hypothesis for the DERAIL MRSA program is that one can safely remove the colonization
      risk from nearly all residents (patients) in a way that does not interfere with the desired
      life-style for persons in these facilities and thereby reduce the risk of infection and lower
      the cost of care by avoiding preventable disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary endpoint will be measuring the reduction in MRSA colonization prevalence
      (percentage rate) in the intervention arm as compared to the control arm. One secondary
      endpoint is to compare the rate of MRSA disease (number of infections per 1,000 patients and
      10,000 patient days) in the intervention and control arms. The other secondary endpoint is to
      determine the cost of MRSA screening and decolonization and compare it to the cost of MRSA
      disease treatment (both medication cost and the expense of any needed hospitalization for
      therapy of MRSA infection therapy) in the control arm. Achieving our primary goal of MRSA
      control will also demonstrate two secondary goals wthe investigators aim to achieve: one
      being that a scientific, planned approach to the issue of specific healthcare-associated
      infection in LTCFs can resolve these problems and the other that a partnership between acute
      and long-term care (e.g., ongoing relationship spanning at least 5 years) is beneficial in
      dealing with patient safety and quality practices across the United Sates Healthcare
      continuum.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To test the effectiveness of an admission testing and immediate decolonization of positive persons protocol for reducing MRSA colonization prevalence in long term care facilities (LTCF's)</measure>
    <time_frame>12 months and 24 months</time_frame>
    <description>Infection Control cluster randomized trial: measuring the reduction in MRSA colonization prevalence (rate) in the intervention arm as compared to the control arm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To further develop an Infection Control Outreach Program designed to provide expert guidance on infectious disease prevention specific to LTCF's</measure>
    <time_frame>2 years</time_frame>
    <description>Compare the rate of MRSA disease in the intervention and control arms. Determine the cost of MRSA screening and decolonization and compare it to the cost of MRSA disease treatment (both medication cost and the expense of any needed hospitalization for therapy of MRSA infection therapy) in the control arm.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22302</enrollment>
  <condition>Methicillin Resistant Staphylococcus Aureus</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active surveillance testing for MRSA and decolonization of positive subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Decolonization</intervention_name>
    <description>5 day regimen of mupirocin calcium 2% twice daily to the nares and any open wound plus bath or shower with 4% chlorhexidine used as a liquid soap</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>Mupirocin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients in 18 LTCF nursing units randomly selected as intervention or control
             units

        Exclusion Criteria:

          -  Patients that choose not to be included in the program
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lance R Peterson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NorthShore University HealthSystem</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NorthShore University HealthSystem Research Institute</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.idph.state.il.us/healthca/nursinghometestjava.htm</url>
    <description>Last assessed March 21, 2010</description>
  </link>
  <link>
    <url>http://www.hhs.gov/ophs/initiatives/hai/2-hai-plan-exec-summ.pdf</url>
    <description>HHS Action Plan to Prevent Healthcare-Associated Infections. Health and Human Services. 2009. Last accessed March 13,2010</description>
  </link>
  <link>
    <url>http://whqlibdoc.who.int/hq/2006/WHO_HTM_STB_2006.368_eng.pdf</url>
    <description>World Health Organization. The Stop TB strategy. WHO 2006. Last accessed March 13,2010</description>
  </link>
  <link>
    <url>http://www.nytimes.com/2006/11/14/opinion/14mccaughey.html?ex=1174795200&amp;en=3e845626c072b4b5&amp;ei=5070.11-14-2006.3-23-2007</url>
    <description>McCaughey B. To catch a deadly germ. New York Times 11/14/2006</description>
  </link>
  <reference>
    <citation>Capitano B, Leshem OA, Nightingale CH, Nicolau DP. Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facility. J Am Geriatr Soc. 2003 Jan;51(1):10-6.</citation>
    <PMID>12534839</PMID>
  </reference>
  <reference>
    <citation>Kauffman CA, Terpenning MS, He X, Zarins LT, Ramsey MA, Jorgensen KA, Sottile WS, Bradley SF. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment. Am J Med. 1993 Apr;94(4):371-8.</citation>
    <PMID>8475930</PMID>
  </reference>
  <reference>
    <citation>Vriens M, Blok H, Fluit A, Troelstra A, Van Der Werken C, Verhoef J. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey. Eur J Clin Microbiol Infect Dis. 2002 Nov;21(11):782-6. Epub 2002 Nov 8.</citation>
    <PMID>12461587</PMID>
  </reference>
  <reference>
    <citation>Smith PW, Bennett G, Bradley S, Drinka P, Lautenbach E, Marx J, Mody L, Nicolle L, Stevenson K; SHEA; APIC. SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008. Infect Control Hosp Epidemiol. 2008 Sep;29(9):785-814. doi: 10.1086/592416.</citation>
    <PMID>18767983</PMID>
  </reference>
  <reference>
    <citation>Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control. 2007 Dec;35(10 Suppl 2):S65-164.</citation>
    <PMID>18068815</PMID>
  </reference>
  <reference>
    <citation>Haley RW, Culver DH, White JW, Morgan WM, Emori TG. The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol. 1985 Feb;121(2):159-67.</citation>
    <PMID>4014113</PMID>
  </reference>
  <reference>
    <citation>Strausbaugh LJ, Joseph CL. The burden of infection in long-term care. Infect Control Hosp Epidemiol. 2000 Oct;21(10):674-9. Review.</citation>
    <PMID>11083186</PMID>
  </reference>
  <reference>
    <citation>Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, Hooton TM. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol. 1985 Feb;121(2):182-205.</citation>
    <PMID>4014115</PMID>
  </reference>
  <reference>
    <citation>John JF Jr, Ribner BS. Antibiotic resistance in long-term care facilities. Infect Control Hosp Epidemiol. 1991 Apr;12(4):245-50.</citation>
    <PMID>1905739</PMID>
  </reference>
  <reference>
    <citation>Muder RR, Brennen C, Wagener MM, Vickers RM, Rihs JD, Hancock GA, Yee YC, Miller JM, Yu VL. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med. 1991 Jan 15;114(2):107-12.</citation>
    <PMID>1984384</PMID>
  </reference>
  <reference>
    <citation>Bradley SF, Terpenning MS, Ramsey MA, Zarins LT, Jorgensen KA, Sottile WS, Schaberg DR, Kauffman CA. Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med. 1991 Sep 15;115(6):417-22.</citation>
    <PMID>1908198</PMID>
  </reference>
  <reference>
    <citation>Strausbaugh LJ, Jacobson C, Sewell DL, Potter S, Ward TT. Methicillin-resistant Staphylococcus aureus in extended-care facilities: experiences in a Veterans' Affairs nursing home and a review of the literature. Infect Control Hosp Epidemiol. 1991 Jan;12(1):36-45. Review.</citation>
    <PMID>1999642</PMID>
  </reference>
  <reference>
    <citation>Boyce JM. Methicillin-resistant Staphylococcus aureus in hospitals and long-term care facilities: microbiology, epidemiology, and preventive measures. Infect Control Hosp Epidemiol. 1992 Dec;13(12):725-37. Review.</citation>
    <PMID>1289400</PMID>
  </reference>
  <reference>
    <citation>Trick WE, Weinstein RA, DeMarais PL, Kuehnert MJ, Tomaska W, Nathan C, Rice TW, McAllister SK, Carson LA, Jarvis WR. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc. 2001 Mar;49(3):270-6.</citation>
    <PMID>11300237</PMID>
  </reference>
  <reference>
    <citation>Stone ND, Lewis DR, Lowery HK, Darrow LA, Kroll CM, Gaynes RP, Jernigan JA, McGowan JE Jr, Tenover FC, Richards CL Jr. Importance of bacterial burden among methicillin-resistant Staphylococcus aureus carriers in a long-term care facility. Infect Control Hosp Epidemiol. 2008 Feb;29(2):143-8. doi: 10.1086/526437.</citation>
    <PMID>18179369</PMID>
  </reference>
  <reference>
    <citation>Brugnaro P, Fedeli U, Pellizzer G, Buonfrate D, Rassu M, Boldrin C, Parisi SG, Grossato A, Palù G, Spolaore P. Clustering and risk factors of methicillin-resistant Staphylococcus aureus carriage in two Italian long-term care facilities. Infection. 2009 Jun;37(3):216-21. doi: 10.1007/s15010-008-8165-1. Epub 2008 Dec 9.</citation>
    <PMID>19148574</PMID>
  </reference>
  <reference>
    <citation>March A, Aschbacher R, Dhanji H, Livermore DM, Böttcher A, Sleghel F, Maggi S, Noale M, Larcher C, Woodford N. Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. Clin Microbiol Infect. 2010 Jul;16(7):934-44. doi: 10.1111/j.1469-0691.2009.03024.x. Epub 2009 Aug 17.</citation>
    <PMID>19686277</PMID>
  </reference>
  <reference>
    <citation>Suetens C, Niclaes L, Jans B, Verhaegen J, Schuermans A, Van Eldere J, Buntinx F. Methicillin-resistant Staphylococcus aureus colonization is associated with higher mortality in nursing home residents with impaired cognitive status. J Am Geriatr Soc. 2006 Dec;54(12):1854-60.</citation>
    <PMID>17198490</PMID>
  </reference>
  <reference>
    <citation>Capitano B, Nicolau DP. Evolving epidemiology and cost of resistance to antimicrobial agents in long-term care facilities. J Am Med Dir Assoc. 2003 May-Jun;4(3 Suppl):S90-9. Review.</citation>
    <PMID>12854980</PMID>
  </reference>
  <reference>
    <citation>Hughes CM, Smith MB, Tunney MM. Infection control strategies for preventing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in nursing homes for older people. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006354. doi: 10.1002/14651858.CD006354.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD006354.</citation>
    <PMID>18254100</PMID>
  </reference>
  <reference>
    <citation>Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, Jensen BJ, Killgore G, Tenover FC, Kuehnert MJ. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis. 2008 May 1;197(9):1226-34. doi: 10.1086/533494.</citation>
    <PMID>18422434</PMID>
  </reference>
  <reference>
    <citation>Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004 Sep 15;39(6):776-82. Epub 2004 Aug 27.</citation>
    <PMID>15472807</PMID>
  </reference>
  <reference>
    <citation>Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis. 2003 Feb 1;36(3):281-5. Epub 2003 Jan 17.</citation>
    <PMID>12539068</PMID>
  </reference>
  <reference>
    <citation>Datta R, Huang SS. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis. 2008 Jul 15;47(2):176-81. doi: 10.1086/589241.</citation>
    <PMID>18532892</PMID>
  </reference>
  <reference>
    <citation>Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003 Jan 1;36(1):53-9. Epub 2002 Dec 13.</citation>
    <PMID>12491202</PMID>
  </reference>
  <reference>
    <citation>Ben-David D, Novikov I, Mermel LA. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection? Infect Control Hosp Epidemiol. 2009 May;30(5):453-60. doi: 10.1086/596731.</citation>
    <PMID>19344266</PMID>
  </reference>
  <reference>
    <citation>Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK; Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007 Oct 17;298(15):1763-71.</citation>
    <PMID>17940231</PMID>
  </reference>
  <reference>
    <citation>Kaye KS, Anderson DJ, Choi Y, Link K, Thacker P, Sexton DJ. The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals. Clin Infect Dis. 2008 May 15;46(10):1568-77. doi: 10.1086/587673.</citation>
    <PMID>18419491</PMID>
  </reference>
  <reference>
    <citation>Humphreys H, Grundmann H, Skov R, Lucet JC, Cauda R. Prevention and control of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2009 Feb;15(2):120-4. doi: 10.1111/j.1469-0691.2009.02699.x. Review.</citation>
    <PMID>19291143</PMID>
  </reference>
  <reference>
    <citation>Delorme T, Rose S, Senita J, Callahan C, Nasr P. Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Northeastern Ohio. Am J Clin Pathol. 2009 Nov;132(5):668-77. doi: 10.1309/AJCPQ46ZPQXVHHNC.</citation>
    <PMID>19846806</PMID>
  </reference>
  <reference>
    <citation>Lindsay JA. Genomic variation and evolution of Staphylococcus aureus. Int J Med Microbiol. 2010 Feb;300(2-3):98-103. doi: 10.1016/j.ijmm.2009.08.013. Epub 2009 Oct 7. Review.</citation>
    <PMID>19811948</PMID>
  </reference>
  <reference>
    <citation>Sung JM, Lloyd DH, Lindsay JA. Staphylococcus aureus host specificity: comparative genomics of human versus animal isolates by multi-strain microarray. Microbiology. 2008 Jul;154(Pt 7):1949-59. doi: 10.1099/mic.0.2007/015289-0.</citation>
    <PMID>18599823</PMID>
  </reference>
  <reference>
    <citation>Grundmann H, Aanensen DM, van den Wijngaard CC, Spratt BG, Harmsen D, Friedrich AW; European Staphylococcal Reference Laboratory Working Group. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med. 2010 Jan 12;7(1):e1000215. doi: 10.1371/journal.pmed.1000215.</citation>
    <PMID>20084094</PMID>
  </reference>
  <reference>
    <citation>Deurenberg RH, Vink C, Kalenic S, Friedrich AW, Bruggeman CA, Stobberingh EE. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2007 Mar;13(3):222-35. Review.</citation>
    <PMID>17391376</PMID>
  </reference>
  <reference>
    <citation>Feil EJ, Cooper JE, Grundmann H, Robinson DA, Enright MC, Berendt T, Peacock SJ, Smith JM, Murphy M, Spratt BG, Moore CE, Day NP. How clonal is Staphylococcus aureus? J Bacteriol. 2003 Jun;185(11):3307-16.</citation>
    <PMID>12754228</PMID>
  </reference>
  <reference>
    <citation>Feil EJ. Small change: keeping pace with microevolution. Nat Rev Microbiol. 2004 Jun;2(6):483-95. Review.</citation>
    <PMID>15152204</PMID>
  </reference>
  <reference>
    <citation>Robicsek A, Beaumont JL, Thomson RB Jr, Govindarajan G, Peterson LR. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol. 2009 Jul;30(7):623-32. doi: 10.1086/597550.</citation>
    <PMID>19496730</PMID>
  </reference>
  <reference>
    <citation>Peterson LR, Hacek DM, Robicsek A. 5 Million Lives Campaign. Case study: an MRSA intervention at Evanston Northwestern Healthcare. Jt Comm J Qual Patient Saf. 2007 Dec;33(12):732-8.</citation>
    <PMID>18200898</PMID>
  </reference>
  <reference>
    <citation>Chang S, Sethi AK, Eckstein BC, Stiefel U, Cadnum JL, Donskey CJ. Skin and environmental contamination with methicillin-resistant Staphylococcus aureus among carriers identified clinically versus through active surveillance. Clin Infect Dis. 2009 May 15;48(10):1423-8. doi: 10.1086/598505.</citation>
    <PMID>19364286</PMID>
  </reference>
  <reference>
    <citation>Smith NH, Gordon SV, de la Rua-Domenech R, Clifton-Hadley RS, Hewinson RG. Bottlenecks and broomsticks: the molecular evolution of Mycobacterium bovis. Nat Rev Microbiol. 2006 Sep;4(9):670-81. Review.</citation>
    <PMID>16912712</PMID>
  </reference>
  <reference>
    <citation>Bowler WA, Bresnahan J, Bradfish A, Fernandez C. An integrated approach to methicillin-resistant Staphylococcus aureus control in a rural, regional-referral healthcare setting. Infect Control Hosp Epidemiol. 2010 Mar;31(3):269-75. doi: 10.1086/650445.</citation>
    <PMID>20102280</PMID>
  </reference>
  <reference>
    <citation>Robicsek A, Beaumont JL, Paule SM, Hacek DM, Thomson RB Jr, Kaul KL, King P, Peterson LR. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med. 2008 Mar 18;148(6):409-18.</citation>
    <PMID>18347349</PMID>
  </reference>
  <reference>
    <citation>Peterson LR, Diekema DJ. To screen or not to screen for methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2010 Mar;48(3):683-9. doi: 10.1128/JCM.02516-09. Epub 2010 Jan 13.</citation>
    <PMID>20071548</PMID>
  </reference>
  <reference>
    <citation>Böcher S, Skov RL, Knudsen MA, Guardabassi L, Mølbak K, Schouenborg P, Sørum M, Westh H. The search and destroy strategy prevents spread and long-term carriage of methicillin-resistant Staphylococcus aureus: results from the follow-up screening of a large ST22 (E-MRSA 15) outbreak in Denmark. Clin Microbiol Infect. 2010 Sep;16(9):1427-34. doi: 10.1111/j.1469-0691.2009.03137.x.</citation>
    <PMID>20041904</PMID>
  </reference>
  <reference>
    <citation>Jernigan JA, Titus MG, Gröschel DH, Getchell-White S, Farr BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol. 1996 Mar 1;143(5):496-504. Erratum in: Am J Epidemiol 1996 May 15;143(10):1079.</citation>
    <PMID>8610665</PMID>
  </reference>
  <reference>
    <citation>Stosor V, Kruszynski J, Suriano T, Noskin GA, Peterson LR. Molecular epidemiology of vancomycin-resistant enterococci: a 2-year perspective. Infect Control Hosp Epidemiol. 1999 Oct;20(10):653-9.</citation>
    <PMID>10530641</PMID>
  </reference>
  <reference>
    <citation>Savor C, Pfaller MA, Kruszynski JA, Hollis RJ, Noskin GA, Peterson LR. Comparison of genomic methods for differentiating strains of Enterococcus faecium: assessment using clinical epidemiologic data. J Clin Microbiol. 1998 Nov;36(11):3327-31.</citation>
    <PMID>9774587</PMID>
  </reference>
  <reference>
    <citation>Jaggi P, Paule SM, Peterson LR, Tan TQ. Characteristics of Staphylococcus aureus infections, Chicago Pediatric Hospital. Emerg Infect Dis. 2007 Feb;13(2):311-4.</citation>
    <PMID>17479900</PMID>
  </reference>
  <reference>
    <citation>Hubbard AE, Ahern J, Fleischer NL, Van der Laan M, Lippman SA, Jewell N, Bruckner T, Satariano WA. To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health. Epidemiology. 2010 Jul;21(4):467-74. doi: 10.1097/EDE.0b013e3181caeb90.</citation>
    <PMID>20220526</PMID>
  </reference>
  <reference>
    <citation>Roy J, Lin X, Ryan LM. Scaled marginal models for multiple continuous outcomes. Biostatistics. 2003 Jul;4(3):371-83.</citation>
    <PMID>12925505</PMID>
  </reference>
  <reference>
    <citation>Paule SM, Mehta M, Hacek DM, Gonzalzles TM, Robicsek A, Peterson LR. Chromogenic media vs real-time PCR for nasal surveillance of methicillin-resistant Staphylococcus aureus: impact on detection of MRSA-positive persons. Am J Clin Pathol. 2009 Apr;131(4):532-9. doi: 10.1309/AJCP18ONZUTDUGAQ.</citation>
    <PMID>19289589</PMID>
  </reference>
  <reference>
    <citation>Mody L, Kauffman CA, McNeil SA, Galecki AT, Bradley SF. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003 Dec 1;37(11):1467-74. Epub 2003 Nov 6.</citation>
    <PMID>14614669</PMID>
  </reference>
  <reference>
    <citation>Suetens C, Niclaes L, Jans B, Verhaegen J, Schuermans A, Van Eldere J, Vandenbroucke JP, Buntinx F. Determinants of methicillin-resistant Staphylococcus aureus carriage in nursing homes. Age Ageing. 2007 May;36(3):327-30. Epub 2007 Mar 29.</citation>
    <PMID>17395619</PMID>
  </reference>
  <reference>
    <citation>Robicsek A, Suseno M, Beaumont JL, Thomson RB Jr, Peterson LR. Prediction of methicillin-resistant Staphylococcus aureus involvement in disease sites by concomitant nasal sampling. J Clin Microbiol. 2008 Feb;46(2):588-92. Epub 2007 Dec 5.</citation>
    <PMID>18057132</PMID>
  </reference>
  <reference>
    <citation>Baker SE, Brecher SM, Robillard E, Strymish J, Lawler E, Gupta K. Extranasal methicillin-resistant Staphylococcus aureus colonization at admission to an acute care Veterans Affairs hospital. Infect Control Hosp Epidemiol. 2010 Jan;31(1):42-6. doi: 10.1086/649222.</citation>
    <PMID>19954335</PMID>
  </reference>
  <reference>
    <citation>Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol. 1996 Dec;17(12):811-3.</citation>
    <PMID>8985769</PMID>
  </reference>
  <reference>
    <citation>McConeghy KW, Mikolich DJ, LaPlante KL. Agents for the decolonization of methicillin-resistant Staphylococcus aureus. Pharmacotherapy. 2009 Mar;29(3):263-80. doi: 10.1592/phco.29.3.263. Review.</citation>
    <PMID>19249946</PMID>
  </reference>
  <reference>
    <citation>Urth T, Juul G, Skov R, Schønheyder HC. Spread of a methicillin-resistant Staphylococcus aureus ST80-IV clone in a Danish community. Infect Control Hosp Epidemiol. 2005 Feb;26(2):144-9.</citation>
    <PMID>15756884</PMID>
  </reference>
  <reference>
    <citation>Boelaert JR. Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review. J Chemother. 1994 Apr;6 Suppl 2:19-24. Review.</citation>
    <PMID>7799051</PMID>
  </reference>
  <reference>
    <citation>Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, Troelstra A, Box AT, Voss A, van der Tweel I, van Belkum A, Verbrugh HA, Vos MC. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010 Jan 7;362(1):9-17. doi: 10.1056/NEJMoa0808939.</citation>
    <PMID>20054045</PMID>
  </reference>
  <reference>
    <citation>Hacek DM, Robb WJ, Paule SM, Kudrna JC, Stamos VP, Peterson LR. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res. 2008 Jun;466(6):1349-55. doi: 10.1007/s11999-008-0210-y. Epub 2008 Mar 18.</citation>
    <PMID>18347889</PMID>
  </reference>
  <reference>
    <citation>Ridenour G, Lampen R, Federspiel J, Kritchevsky S, Wong E, Climo M. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol. 2007 Oct;28(10):1155-61. Epub 2007 Aug 1.</citation>
    <PMID>17828692</PMID>
  </reference>
  <reference>
    <citation>Eveillard M, Charru P, Rufat P, Hippeaux MC, Lancien E, Benselama F, Branger C. Methicillin-resistant Staphylococcus aureus carriage in a long-term care facility: hypothesis about selection and transmission. Age Ageing. 2008 May;37(3):294-9. doi: 10.1093/ageing/afn021. Epub 2008 Feb 12.</citation>
    <PMID>18270245</PMID>
  </reference>
  <reference>
    <citation>Munoz-Price LS, Hayden MK, Lolans K, Won S, Calvert K, Lin M, Stemer A, Weinstein RA. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol. 2010 Apr;31(4):341-7. doi: 10.1086/651097.</citation>
    <PMID>20175685</PMID>
  </reference>
  <reference>
    <citation>Centers for Disease Control and Prevention (CDC). Trends in tuberculosis--United States, 2004. MMWR Morb Mortal Wkly Rep. 2005 Mar 18;54(10):245-9. Erratum in: MMWR Morb Mortal Wkly Rep. 2005 Jun 8;293(22):2712.</citation>
    <PMID>15772584</PMID>
  </reference>
  <reference>
    <citation>O'Dowd A. NHS may miss target on reducing MRSA by 2008, minister says. BMJ 2006;333(7575:938</citation>
  </reference>
  <reference>
    <citation>Peterson LR, Hacek DM, Beaumont JL, Boehm S, Gonzolzaes T-M, Gocht N, Robicsek A. Impact of a 4-Year Universal Surveillance and Decolonization Program to Control Methicillin-Resistant Staphylococcus aureus (MRSA). In Program and Abstracts, Fifth Decennial International Conference on Healthcare-Associated Infection. Atlanta, GA. March 18-22, 2010</citation>
  </reference>
  <reference>
    <citation>Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, Twombley J, French PP, Herwaldt LA; Mupirocin And The Risk Of Staphylococcus Aureus Study Team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002 Jun 13;346(24):1871-7.</citation>
    <PMID>12063371</PMID>
  </reference>
  <reference>
    <citation>Robicsek A, Paule SM, Hacek DM, Gonzalzles TM, Thomson RB, Peterson LR. How long after colonization does MRSA disease occur? IN: Program and Abstracts, Forty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washinton, D.C., October 25-28, 2008. Abstract K-1708.</citation>
  </reference>
  <reference>
    <citation>Robicsek A, Hacek DM, Fisher A, Peterson LR. Progression to MRSA infection in asymptomatic carriers (AC) detected through a hospital-based universal surveillance and decolonization program. IN: Program and Abstracts. Forty-fourth Annual Meeting, Infectious Diseases Society of America, Toronto, Canada, October 12-15, 2006. Abstract 390.</citation>
  </reference>
  <reference>
    <citation>Hacek D, Paule S, Small M, Gottschall R, Thomson R, Peterson L. Comparison of colisitin naladixic agar (CNA), mannitol salt agar (MS) and phenol mannitol broth with antibiotics (PMB) for the recovery of Staphylococcus aureus (SA) from nasal swabs. Abstracts of the One-hundreth and third Annual Meeting of the American Society for Microbiology,Washinto, DC. May 18-22,2003. Abstract C-323.</citation>
  </reference>
  <reference>
    <citation>Paule S, Robicsek A, Suseno M, Kaul KL, Peterson LR. Incidence of mupirocin resistance in methicillin-resistant Staphylococcus aureus (MRSA) during universal surveillance and decolonization. IN: Program and Abstracts, Forty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 27-30,2006. Abstract C2-1149.</citation>
  </reference>
  <results_reference>
    <citation>Peterson LR, Boehm S, Beaumont JL, Patel PA, Schora DM, Peterson KE, Burdsall D, Hines C, Fausone M, Robicsek A, Smith BA. Reduction of methicillin-resistant Staphylococcus aureus infection in long-term care is possible while maintaining patient socialization: A prospective randomized clinical trial. Am J Infect Control. 2016 Dec 1;44(12):1622-1627. doi: 10.1016/j.ajic.2016.04.251. Epub 2016 Aug 1.</citation>
    <PMID>27492790</PMID>
  </results_reference>
  <results_reference>
    <citation>Schora DM, Boehm S, Das S, Patel PA, O'Brien J, Hines C, Burdsall D, Beaumont J, Peterson K, Fausone M, Peterson LR. Impact of Detection, Education, Research and Decolonization without Isolation in Long-term care (DERAIL) on methicillin-resistant Staphylococcus aureus colonization and transmission at 3 long-term care facilities. Am J Infect Control. 2014 Oct;42(10 Suppl):S269-73. doi: 10.1016/j.ajic.2014.05.011.</citation>
    <PMID>25239721</PMID>
  </results_reference>
  <results_reference>
    <citation>Das S, Anderson CJ, Grayes A, Mendoza K, Harazin M, Schora DM, Peterson LR. Nasal Carriage of Epidemic Methicillin-Resistant Staphylococcus aureus 15 (EMRSA-15) Clone Observed in Three Chicago-Area Long-Term Care Facilities. Antimicrob Agents Chemother. 2013 Sep;57(9):4551-4553. doi: 10.1128/AAC.00528-13. Epub 2013 Jun 24.</citation>
    <PMID>23796939</PMID>
  </results_reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2011</study_first_submitted>
  <study_first_submitted_qc>February 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2011</study_first_posted>
  <last_update_submitted>February 10, 2018</last_update_submitted>
  <last_update_submitted_qc>February 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>NorthShore University HealthSystem Research Institute</investigator_affiliation>
    <investigator_full_name>Lance Peterson</investigator_full_name>
    <investigator_title>Epidemiologist</investigator_title>
  </responsible_party>
  <keyword>MRSA</keyword>
  <keyword>Cluster Randomized Trial</keyword>
  <keyword>Infection Control Intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Staphylococcal Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mupirocin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

